Neuropatía óptica por etambutol en paciente con esclerosis múltiple
- V. Gómez Calleja 1
- P. Pérez García 1
- F. Ly Yang 1
- E. Santos Bueso 1
-
1
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
info
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Madrid, España
ISSN: 0365-6691
Year of publication: 2022
Volume: 97
Issue: 1
Pages: 52-57
Type: Article
More publications in: Archivos de la Sociedad Española de Oftalmologia
Abstract
We present the clinical case of a patient who developed a toxic optic neuropathy due to ethambutol in the context of a tuberculosis reactivation and who also had a personal history of multiple sclerosis. The objective is to highlight the importance of making a good differential diagnosis of this adverse effect and of knowing its main clinical, campimetric and tomographic manifestations and characteristics. Furthermore, since the reversibility of damage is still discussed in the literature, early diagnosis is essential. For this purpose, it is important to inform the patient of the possible symptoms and to carry out an ophthalmological examination and colour tests before starting treatment to assess whether there is progression.